Page last updated: 2024-12-05
1,2-dimethylimidazole
1,2-Dimethylimidazole is a heterocyclic organic compound with the formula C5H8N2. It is a colorless liquid with a pungent odor. 1,2-Dimethylimidazole is an important building block for the synthesis of various pharmaceuticals, agrochemicals, and other fine chemicals. The compound is also a precursor to the synthesis of several important organic compounds, such as N-methyl-imidazole, which is used as a catalyst in organic synthesis. It is studied due to its potential applications in the pharmaceutical and agricultural industries. It is also studied for its potential to serve as a building block for the development of new materials with unique properties.'
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 15617 |
| CHEBI ID | 190967 |
| MeSH ID | M0101798 |
Synonyms (43)
| Synonym |
|---|
| ec 217-101-2 |
| q41bc3grjb , |
| unii-q41bc3grjb |
| nsc 111174 |
| einecs 217-101-2 |
| imidazole, 1,2-dimethyl- |
| 1h-imidazole, 1,2-dimethyl- |
| 1,2-dimethyl imidazole |
| 1h-imidazole,2-dimethyl- |
| nsc111174 |
| imidazole,2-dimethyl- |
| 1,2-dimethylimidazole |
| 1739-84-0 |
| nsc-111174 |
| 1,2-dimethylimidazole, 98% |
| inchi=1/c5h8n2/c1-5-6-3-4-7(5)2/h3-4h,1-2h3 |
| giwqspitlqvmsg-uhfffaoysa- |
| D1562 |
| CHEBI:190967 |
| AKOS000121115 |
| A811589 |
| BBL011425 |
| 1,2-dimethyl-1h-imidazole |
| STL146532 |
| FT-0606427 |
| AM20090037 |
| 1h-imidazole, dimethyl- |
| DTXSID2061939 |
| 1,2 dimethylimidazole |
| n,2-dimethylimidazole |
| 1,2-dimethyl-1h-imidazole # |
| W-107856 |
| mfcd00005294 |
| F0001-0633 |
| AC-8725 |
| CS-W016663 |
| D78061 |
| Q27286970 |
| LS-09569 |
| 1,2-dimethylimidazole, >98% |
| EN300-26570 |
| PD040814 |
| 1,2-dimethylimidazol |
Drug Classes (1)
| Class | Description |
|---|
| imidazoles | A five-membered organic heterocycle containing two nitrogen atoms at positions 1 and 3, or any of its derivatives; compounds containing an imidazole skeleton. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 34.12
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 34.12 (24.57) | | Research Supply Index | 2.08 (2.92) | | Research Growth Index | 4.66 (4.65) | | Search Engine Demand Index | 38.91 (26.88) | | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |